Workflow
Earnings ESP
icon
Search documents
fuboTV Inc. (FUBO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
ZACKS· 2025-07-29 15:01
Revenues are expected to be $354.45 million, down 8.9% from the year-ago quarter. Estimate Revisions Trend The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change. Price, Consensus and EPS ...
Gulfport Energy (GPOR) Reports Next Week: Wall Street Expects Earnings Growth
ZACKS· 2025-07-29 15:01
Core Viewpoint - Gulfport Energy (GPOR) is anticipated to report a year-over-year increase in earnings driven by higher revenues, with the actual results being a significant factor influencing its near-term stock price [1][2]. Earnings Expectations - The upcoming earnings report is expected to be released on August 5, with a consensus EPS estimate of $5.03 per share, reflecting a year-over-year increase of +72.9%. Revenues are projected to be $334.57 million, up 84.7% from the previous year [3][2]. - The consensus EPS estimate has been revised 13.93% lower over the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that Gulfport's Most Accurate Estimate aligns with the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%. The stock currently holds a Zacks Rank of 3, making it challenging to predict an earnings beat [12]. - Historically, Gulfport has beaten consensus EPS estimates in the last four quarters, with a notable surprise of +8.14% in the last reported quarter [13][14]. Industry Context - In the broader industry context, W&T Offshore (WTI) is expected to report a loss of $0.14 per share for the same quarter, indicating a year-over-year change of -180%. Its revenue is projected to be $135.53 million, down 5.1% from the previous year [18]. - W&T Offshore's consensus EPS estimate has been revised 6.3% lower, but it has a positive Earnings ESP of +16.28%, suggesting a likelihood of beating the consensus EPS estimate [19][20].
Hamilton Lane (HLNE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
ZACKS· 2025-07-29 15:01
The market expects Hamilton Lane (HLNE) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The earnings report, which is expected to be released on August 5, might help the stock move higher if these key numbers are better ...
Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ZACKS· 2025-07-29 15:01
Company Overview - Harmony Biosciences Holdings, Inc. (HRMY) is expected to report a year-over-year increase in earnings driven by higher revenues for the quarter ended June 2025, with a consensus EPS estimate of $0.82, reflecting a +310% change [1][3] - Revenue expectations stand at $203.38 million, which is a 17.7% increase from the same quarter last year [3] Earnings Expectations - The earnings report is anticipated to be released on August 5, and the stock may rise if actual results exceed expectations; conversely, a miss could lead to a decline [2] - The consensus EPS estimate has been revised down by 5.2% over the last 30 days, indicating a bearish sentiment among analysts [4] Earnings Surprise Prediction - The Most Accurate Estimate for Harmony Biosciences is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -2.31%, which complicates predictions of an earnings beat [12] - Despite the negative Earnings ESP, the company holds a Zacks Rank of 2 (Buy), suggesting potential for positive performance [12] Historical Performance - In the last reported quarter, Harmony Biosciences had an earnings surprise of +32.20%, with actual earnings of $0.78 per share compared to an expected $0.59 [13] - The company has successfully beaten consensus EPS estimates in the last four quarters [14] Industry Context - In the broader Zacks Medical - Biomedical and Genetics industry, Vertex Pharmaceuticals (VRTX) is also expected to report strong earnings, with an EPS estimate of $4.24, reflecting a +133.1% year-over-year change and revenues of $2.89 billion, up 9.2% [18][19] - Vertex has an Earnings ESP of +1.55% and a Zacks Rank of 3 (Hold), indicating a likelihood of beating the consensus EPS estimate [19][20]
Analysts Estimate J&J Snack Foods (JJSF) to Report a Decline in Earnings: What to Look Out for
ZACKS· 2025-07-29 15:01
Wall Street expects a year-over-year decline in earnings on higher revenues when J&J Snack Foods (JJSF) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on August 5. ...
Lucid Group (LCID) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
ZACKS· 2025-07-29 15:01
This an electric vehicle automaker is expected to post quarterly loss of $0.22 per share in its upcoming report, which represents a year-over-year change of +24.1%. Lucid Group (LCID) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near ...
Earnings Preview: Jazz Pharmaceuticals (JAZZ) Q2 Earnings Expected to Decline
ZACKS· 2025-07-29 15:01
Jazz Pharmaceuticals (JAZZ) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on Aug ...
MYR Group to Release Q2 Earnings: What's in Store for the Stock?
ZACKS· 2025-07-29 14:51
Key Takeaways MYRG is set to report Q2 results on July 30, with EPS expected to surge 271.4% year over year.Strong demand in clean energy, data centers and infrastructure is likely to have boosted Q2 performance.MYRG's expansion in core markets and shifting energy trends are expected to have supported earnings.MYR Group Inc. (MYRG) is scheduled to release second-quarter 2025 results on July 30, after market close. The company delivered an earnings surprise of 17.89% in the last reported quarter. Let us disc ...
Linde Gears Up to Report Q2 Earnings: What's in Store for the Stock?
ZACKS· 2025-07-29 14:51
Core Viewpoint - Linde plc is expected to report its second-quarter 2025 results on August 1, with earnings per share estimated at $4.03 and revenues at $8.35 billion, reflecting a year-over-year improvement in earnings and revenues [1][3][9]. Group 1: Q1 Performance and Expectations - In the previous quarter, Linde's earnings were $3.95 per share, surpassing the Zacks Consensus Estimate of $3.93, driven by higher pricing and increased volumes from the Americas segment [2]. - The Zacks Consensus Estimate for second-quarter earnings per share is $4.03, indicating a 4.68% improvement from the prior-year quarter [2]. - The expected revenue for the second quarter is $8.35 billion, which represents a year-over-year increase of 1.04% [3]. Group 2: Market Position and Performance Factors - Linde is a global leader in industrial gas production, serving various end markets including healthcare, manufacturing, and chemicals & refining [4]. - The company is anticipated to maintain stable performance due to long-term contracts with major on-site clients and operations in resilient end markets such as healthcare and food and beverages [5]. - However, challenges may arise from tariffs and changes in trade policies, which could slow down industrial activity globally, particularly affecting demand in markets like China and Europe [6]. Group 3: Segment Performance Estimates - The Zacks Consensus Estimate for operating profit in the Americas segment is $1.19 billion, an increase from $1.16 billion in the second quarter of 2024 [7]. - The operating profit estimate for the Engineering business unit is $100 million, up from $96 million a year ago [7]. - These factors are expected to influence demand and pricing dynamics, potentially impacting Linde's quarterly performance [7].
ExxonMobil Before Q2 Earnings: Time to Hold the Stock or Reassess?
ZACKS· 2025-07-29 14:05
Core Viewpoint - Exxon Mobil Corporation (XOM) is expected to report a significant decline in second-quarter earnings and revenues due to lower oil and natural gas prices, with earnings estimated at $1.49 per share, reflecting a 30.4% year-over-year decrease [2][6]. Financial Performance - The Zacks Consensus Estimate for second-quarter revenues is $82.8 billion, indicating an 11% decline from the previous year [2]. - XOM has consistently beaten earnings estimates in the past four quarters, with an average surprise of 3.58%, but the current model does not predict an earnings beat for this quarter [3][4]. Market Conditions - The average spot prices for West Texas Intermediate (WTI) crude oil in the second quarter were lower than in the first quarter, with prices of $63.54, $62.17, and $68.17 per barrel for April, May, and June respectively, compared to $75.74, $71.53, and $68.24 per barrel in the first quarter [7]. - Lower oil prices are expected to reduce XOM's upstream earnings by $800 million to $1.2 billion, while natural gas price changes may decrease profits by $300 million to $700 million [8]. Valuation Metrics - XOM's current EV/EBITDA ratio is 6.90, which is above the industry average of 4.35, indicating that the stock may be overvalued despite its lower price compared to peers like BP and Chevron [6][11]. Strategic Developments - The acquisition of Pioneer Natural Resources enhances XOM's production capabilities in the Permian Basin, a region known for low production costs [13]. - The company is also investing in alternative energy projects, such as carbon capture and lithium battery technology, which present potential growth opportunities but require significant capital [14]. Competitive Landscape - Other major energy players like Chevron and BP are also set to report second-quarter earnings, with Chevron having a positive Earnings ESP of +3.63% and BP at 0.00% [15][16].